首页> 外文会议>International Symposium on Applied Chemistry >Targetting the hemozoin synthesis pathway for antimalarial drug and detected by TEM (Transmission electron microscope)
【24h】

Targetting the hemozoin synthesis pathway for antimalarial drug and detected by TEM (Transmission electron microscope)

机译:针对血液沸素合成途径进行抗疟药,由TEM(透射电子显微镜)检测

获取原文

摘要

Malaria is a major public health problem mainly due to the development of resistance by the most lethal causative parasite species, the alarming spread of drug resistance and limited number of effective drug available now. Therefore it is important to discover new antimalarial drug. Malaria is caused by a singlecelled parasite from the genus Plasmodium. Plasmodium falciparum parasite infect red blood cells, ingesting and degradation hemoglobin in the acidic food vacuola trough a sequential metabolic process involving multiple proteases. During these process, hemoglobin is utilized as the predominant source of nutrition. Proteolysis of hemoglobin yields amino acid for protein synthesis as well as toxic heme. Massive degradation of hemoglobin generates large amount of toxic heme. Malaria parasite has evolved a distinct mechanism for detoxification of heme through conversion into insoluble crystalline pigment, known as hemozoin (β hematoin). Hemozoin synthesis is an indispensable process for the parasite and is the target for action of several known antimalarial drug. TEM (Transmission Electron Microscope) technology for hemozoin formation in vitro assay was done in this research. Calophyllum aerophyllum Lauterb as medicinal plants was used as a source of antimalarial drug. Acetone extracts of C. lowii showed growth inhibition against parasite P. falciparum with IC50 = 5.2 μg/mL. Whereas from hexane, acetone and methanol fraction of C. aerophyllum showed growth inhibition with IC50 = 0.054, 0.055 and 0.0054 μg/mL respectively. New drug from Calophyllum might have potential compounds that have unique structures and mechanism of action which required to develop new drug for treatment of sensitive and drug resistant strain of malaria.
机译:疟疾是一个主要的公共卫生问题主要是由于最致命的致病性寄生虫物种的抗性发展,耐药性令人震惊的蔓延和有限的有效药物可用。因此,发现新的抗疟药药物很重要。疟疾是由来自属疟原虫属的单身寄生虫引起的。恶性疟原虫寄生虫感染红细胞,在酸性食物液体中摄取和降解血红蛋白,涉及多种蛋白酶的连续代谢过程。在这些过程中,血红蛋白被用作营养的主要来源。血红蛋白的蛋白水解产生蛋白质合成的氨基酸以及毒性血红素。血红蛋白的大量降解产生大量有毒血红素。疟疾寄生虫通过转化成不溶性结晶颜料,进化了血红素的解毒机制,称为血液酶(β骨苷)。血液沸石合成是寄生虫的不可或缺的方法,是几种已知的抗疟药的作用的靶标。在本研究中,在体外测定中进行血液素形成的TEM(透射电子显微镜)技术。 Calophyllum Aerophyllum Lauterb作为药用植物用作抗疟药源。丙酮萃取物的C.Regii显示出对寄生虫P. Falciparum的生长抑制与IC50 =5.2μg/ mL。从己烷中,丙酮和甲醇馏分的丙酮和甲醇馏分分别与IC50 = 0.054,0.055和0.0054μg/ mL显示出生长抑制。来自Calophylum的新药可能具有潜在的化合物,具有独特的结构和机制,需要开发新药来治疗疟疾敏感和耐药菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号